BREAKING: Connecticut Attorney General Demands Five Manufacturers Cease 340B Actions

“Denying outpatient access to appropriate 340B drug pricing is a clear violation of federal law,” Connecticut Attorney General William Tong warned five drug manufacturers today about their restrictions on 340B pricing on drugs dispensed by contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content

*Sign up for news summaries and alerts from 340B Report